Invention Grant
![Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)methanol (compound 1)](/docs/US/2023-05-16/US11649239B2/abs.jpg.600x600.jpg)
- Patent Title: Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)methanol (compound 1)
-
Application No.: US17044127Application Date: 2019-04-28
-
Publication No.: US11649239B2Publication Date: 2023-05-16
- Inventor: Kevin X. Chen , Yanxin Yu , Xinde Chen , Li Zhang , Zhaoguo Chen , Cheng Xie
- Applicant: Medshine Discovery Inc.
- Applicant Address: CN Jiangsu
- Assignee: Medshine Discovery Inc.
- Current Assignee: Medshine Discovery Inc.
- Current Assignee Address: CN Jiangsu
- Agency: McDermott Will & Emery LLP
- Priority: CN 1810399876.6 2018.04.28
- International Application: PCT/CN2019/084822 2019.04.28
- International Announcement: WO2019/206336A 2019.10.31
- Date entered country: 2020-09-30
- Main IPC: C07D487/04
- IPC: C07D487/04
![Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)methanol (compound 1)](/abs-image/US/2023/05/16/US11649239B2/abs.jpg.150x150.jpg)
Abstract:
Disclosed in the present invention are a crystal form of a [1,2,4]triazolo[1,5-c]pyrimidine compound and a preparation method thereof. Further disclosed is a use of the crystal form in the preparation of a medicament for treating A2A receptor related diseases.
Public/Granted literature
- US20210094957A1 CRYSTAL FORM AND SALT TYPE OF TRIAZOLOPYRIMIDINE COMPOUND AND PREPARATION METHOD THEREOF Public/Granted day:2021-04-01
Information query
